Studies have indicated that cholinergic neurons in the basal forebrain of patients with Alzheimer’s disease (AD) are absent, the activity of acetylcholinesterase (AChE) is increased, and the content of acetylcholine, a neurotransmitter, is decreased. This evidence concerns the gene ACHE and Alzheimer disease.